At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Transcranial alternating current stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory
In Brief
A clinical study evaluating Transcranial alternating current stimulation for Mild Cognitive Impairment. Completed, enrolled 14 participants across 1 site.
Detailed Summary
This project assessed the feasibility of transcranial alternating current stimulation in the gamma band to lower beta-amyloid load and improve memory performance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMild Cognitive Impairment
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartJan 2021
Primary CompletionDec 2021
Study CompletionMay 2022
TodayJul 2026
First PostedNov 30, 2020
Enrollment StartJan 18, 2021
Primary CompletionDec 31, 2021
Study CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.6 years ago
Interventions
Transcranial alternating current stimulationdevice
Transcranial alternating current stimulation (tACS) will be applied at 40 Hz (gamma band) during eight sessions over the course of a month.